Ananth Akkiraju MS PMP

Ananth Akkiraju, MS, PMP has a diverse work experience in the biotechnology and pharmaceutical industry. Ananth'smost recent role is as an Associate Director of CMC Operations and Strategy at Affini-T Therapeutics, where they began in September 2021. Prior to that, they worked at Sarepta Therapeutics as a CMC Operations and Project Management specialist from February 2020 to August 2021. From June 2019 to February 2020, they held a position as a Senior CMC Project Manager at Intellia Therapeutics, Inc. Before that, they worked at Stealth Biotherapeutics as a CMC Project Manager and Stability Specialist from February 2016 to June 2019. Earlier in their career, Ananth worked at bluebird bio as an Associate Scientist II, handling various responsibilities related to cell-based assays, data analysis, and coordination of quality control testing. Ananth also has experience at Genzyme, a Sanofi company, as a Quality Control Analyst II and at MassBiologics as a Quality Control Analyst. Ananth began their career in research, with positions at Boston University and MassBay Community College, where they conducted scientific research and presented their work at conferences. Overall, Ananth Akkiraju has developed a strong background in project management and CMC operations within the biotech industry.

Ananth Akkiraju, MS, PMP has a varied education history, with a strong focus on project management. Ananth first pursued a Bachelor of Science (BS) degree in Biochemistry at UMass Boston from 2004 to 2008. Later, they returned to Northeastern University to earn their first Master of Science (MS) degree in Project Management, with no specified start or end year. Ananth continued to deepen their knowledge in project management by pursuing a second MS degree in the same field from Northeastern University from 2017 to 2019.

Ananth'spassion for learning and staying current in their field led him to enroll at the prestigious Massachusetts Institute of Technology (MIT) in 2020. At MIT, Ananth is currently studying Artificial Intelligence, although the specific degree name and end year have not yet been provided. This demonstrates their commitment to expanding their skill set and exploring emerging fields.